TIAA CREF Investment Management’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

TIAA CREF Investment Management’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$223K	Hold	25,092	–	–	﹤0.01%	2865
2018 Q4	$190K	Hold	25,092	–	–	﹤0.01%	2887
2018 Q3	$526K	Sell	25,092 -1,073	-4%	-$25.6K	﹤0.01%	2693
2018 Q2	$783K	Buy	26,165 +16,230	+163%	+$442K	﹤0.01%	2592
2018 Q1	$269K	Buy	9,935 +2,143	+28%	+$64.1K	﹤0.01%	2928
2017 Q4	$224K	Sell	7,792 -618	-7%	-$16.9K	﹤0.01%	2990
2017 Q3	$204K	Buy	+8,410	New	+$199K	﹤0.01%	3040

Other funds holding DOVA

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TIAA CREF Investment Management's DOVA Position: Q1 2019 in Review

TIAA CREF Investment Management held its Dova Pharmaceuticals, Inc. Common Stock (DOVA) position steady in Q1 2019 at 25,092 shares worth $223K. The position accounts for ﹤0.01% of the portfolio, ranked #2865.

TIAA CREF Investment Management first reported a position in DOVA in Q3 2017 and has held it in 7 quarters since. The position peaked at $783K in Q2 2018. 59 funds tracked by Wall St. Rank hold DOVA as of Q1 2019.

TIAA CREF Investment Management held 25,092 shares of Dova Pharmaceuticals, Inc. Common Stock worth $223K as of Q1 2019.
TIAA CREF Investment Management left its Dova Pharmaceuticals, Inc. Common Stock share count unchanged in Q1 2019.
Dova Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2865 holding.
TIAA CREF Investment Management first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q3 2017 and has held it in 7 quarters since.
TIAA CREF Investment Management's Dova Pharmaceuticals, Inc. Common Stock position peaked at $783K in Q2 2018.
59 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.